Navigation Links
Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
Date:4/12/2011

ression, which were resolved via dose adjustment in two cases and discontinuance in the third. One patient experienced a pulmonary embolism 19 days post-surgery secondary to an iliac vein thrombosis, unlikely related to the cells. All adverse events were resolved. In the group of ambulatory patients, all three remain ambulatory and experienced no serious adverse events secondary to surgery.  

"It has been 15-to-4 months since the first nine patients have received the cells," said Karl Johe, Ph.D., Chief Scientific Officer and Chairman of Neuralstem's Board of Directors.  "There have been no adverse reactions possibly or probably or definitely related to the cells.  This indicates that the trial is proceeding as smoothly as can be hoped for. It is designed for transplantation to progress up to the cervical region of spinal cord as safety is demonstrated in the lumbar region," Dr. Johe continued. "With SMB and FDA review of the safety data from the 12 patients due to be completed in the next month, we hope to begin transplanting ALS patients in the cervical region this summer."

"This is significant and, we believe, compelling safety data," said Richard Garr president and CEO of Neuralstem. "It represents the first safety results from the world's first ALS neural stem cell trial, as well as the first data from Neuralstem's ongoing clinical programs. We believe it also validates our proprietary Spinal Injection Platform for the safe intraspinal delivery of our cells.  We  remain deeply indebted to the patients and their families who are participating in the study."

About the Study

Safety results were presented on nine patients in an ongoing Phase I study to evaluate the safety of Neuralstem's spinal cord stem cells (HSSC's), as well as the transplantation technique, in the treatment of ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease).

Of these nine patients, the first six (Cohort A) were a
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
2. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
3. /C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/
4. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
5. Par Pharmaceutical Announces Modified Dutch Auction Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
6. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
7. Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for Modified Dutch Auction Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note
8. International Merchant Advisors Reaches Agreement in Principal to Acquire First Medical Marijuana Clinic Operations
9. NeoStem Announces Warrant Exercise by Principal Shareholder
10. Pascal Metrics Welcomes Jim Conway to Leadership Team as Principal
11. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Today, Wall Street Reports ... GILD ), Health Management Associates Inc. (NYSE: ... ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), and Trius ... free of charge - including full price targets, industry analysis ... Gilead Sciences, Inc. Research Report On June 7, ...
(Date:6/18/2013)... SALT LAKE CITY , June 18, 2013 ... registry-based informatics products for healthcare and life sciences ... U.S. General Services Administration (GSA) IT Schedule 70 ... is now certified to provide innovative IT solutions ... levels. In accordance with this contract, Remedy has ...
(Date:6/18/2013)... 2013 Apama Medical, a privately held ... next-generation atrial fibrillation technologies, today announced the issuance ... Patent and Trademark Office (USPTO), titled "Low Profile ... for use on expandable structures such as balloons ... "We are grateful to the NSF ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4
... announced that data,presented recently at the 17th Annual ... that the Genous Bio-engineered R,stent has better outcomes ... Federico Piscione, M.D., the study,s principal,investigator and a ... of Cardiology, Department of Clinical Medicine and Cardiovascular,Sciences, ...
... Results are basis for CTI,s Marketing Authorization Application currently ... under ... Inc. (CTI),(Nasdaq: CTIC ; MTA) today announced the publication of ... gemcitabine or vinorelbine for the treatment of PS 2,(performance status 2) ...
Cached Medicine Technology:Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5
(Date:6/18/2013)... University Hospitals Case Medical Center clinical researchers have ... design, which will evaluate the ability of a ... in end stage peripheral arterial disease (PAD). ... Vascular Surgery at University Hospitals Case Medical Center,s ... Surgery at Case Western Reserve University School of ...
(Date:6/18/2013)... June 18, 2013 More than 1.1 million ... with HIV/AIDS, according to the Centers for Disease Control and ... are infected. In support of National HIV Testing Day on ... Disability Insurance (SSDI) representation, the CDC and other organizations ... , The CDC reports about 50,000 new HIV infections each ...
(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...
(Date:6/18/2013)... 18, 2013 A new $119 million ... burgeoning aquaculture industry is redefining the way consumers get ... most acclaimed personal culinary chefs on the Emerald Coast ... of sustainable seafood and the promising industry of aquaculture. ... days. Many consumers strive to fully partake in the ...
(Date:6/18/2013)... 18, 2013 David Connett, DO, vice ... Medicine for the College of Osteopathic Medicine of the ... been elected president of the Osteopathic Medical Board ... Jr. appointed Connett, a 1984 alumnus of COMP, to ... elected Connett to the position during a conference call. ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:New $119 Million Industry Swimming Up the East Coast 2
... surgery should be considered earlier in the treatment of ... can result from diabetes, according to an International Diabetes ... the 2nd World Congress on Interventional Therapies for Type ... written by 20 leading experts in diabetes and bariatric ...
... MONDAY, March 28 (HealthDay News) -- Seeing other people ... itch, researchers suggest. The team at Wake Forest ... as "contagious itch." "It is conceivable that the ... similar to the ones involved in contagious yawning, a ...
... yoga to martial arts, women have been pummelled by the ... pursuit of the pervasive fit, feminine ideal: to look young, ... Exercise: The Body, Health and Consumerism edited by Pirkko Markula, ... on the complex relationships between women and exercise. It,s a ...
... in the black percentage of crime may be dampened ... group of criminologists. The rise in the U.S. Hispanic ... during the late 1980s and early 1990s may skew ... National Crime Victimization Survey that appear to show a ...
... March 25, 2011 Shannon Fortin, a University of ... been selected as a 2011-12 Achievement Rewards for College ... Fortin to continue pursuing two simultaneous post-graduate degrees at ... medical degree at the UA College of Medicine-Phoenix, and ...
... has found that certain types of women with early stage ... Published early online in CANCER, a peer-reviewed journal ... worrying about cancer recurrence can compromise patients, medical care and ... most women who are diagnosed with early stage breast cancer ...
Cached Medicine News:Health News:International Diabetes Federation supports surgery to treat diabetes 2Health News:International Diabetes Federation supports surgery to treat diabetes 3Health News:Seeing Others Scratch Can Trigger Your Own Itch 2Health News:Through women's eyes: Conflicting fitness messages underscore women's fit body stereotypes 2Health News:Demographics cloud optimism on black violent crime decrease 2Health News:TGen, UA student-researcher extends string of coveted scholarships 2Health News:Certain breast cancer patients worry excessively about recurrence 2
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The BD Vacutainer® One Use Holder is a quality, low-cost single use holder that can help customers comply with OSHA regulations (Safety and Health Information Bulletin 10-15-03)...
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Inquire...
Medicine Products: